Effect of salvia miltiorrhiza and ligustrazine hydrochloride injection combined with hydroxyethyl starch injection on serum BNP, Hcy, MMP-2, S100B protein and hemorheology in patients with acute cerebral watershed infarction

Objective:To study the effect of salvia miltiorrhiza and ligustrazine hydrochloride injection combined with hydroxyethyl starch injection on serum BNP, Hcy, MMP-2, S100B protein and hemorheology in patients with acute cerebral watershed infarction.Methods:A total of 90 patientswith acute cerebral watershed infarction in our hospital from August 2014 to December 2016 were enrolled in this study. The subjects were divided into the control group (n=45) and the treatment group (n=45) randomly. The control group was treated with hydroxyethyl starch injection, the treatment group was treated withsalvia miltiorrhiza and ligustrazine hydrochloride injection combined with hydroxyethyl starch injection, and both the two groups were treated for 2 weeks. The serum BNP, Hcy, MMP-2, S100B protein and hemorheology of the two groups before and after treatments were compared.Results:There were no significantly differences of the serum BNP, Hcy, MMP-2, S100B protein and hemorheology of the two groups before treatment. The serum BNP, Hcy, MMP-2, S100B proteinlevels of the two groups after treatment were significantly lower than before treatment, and that of the treatment group after treatment were significantly lower than the control group. The PV, Lr, Mr, Hr and RE of the two groups after treatment were significantly lower than before treatment, and that of the treatment group after treatment were significantly lower than the control group.Conclusion:Salvia miltiorrhiza and ligustrazine hydrochloride injection combined with hydroxyethyl starch injectioncan significantlyimprovetheneurological function and hemorheology, reduce inflammation of the patients with acute cerebral watershed infarction, and it was worthy clinical application.

TREATMENT OF 40 CASES OF CHRONIC ECZEMA WITH POINT-INJECTION OF COMPOUND RADIX SALVIAE MILTIORRHIZAE INJECTION

The authors have used point-injection of compound Radix Salviae Miltiorrhizae Injection to treat 40 cases of chronic eczema and achieved a satisfactory therapeutic effect. The total effective rate was 95%.

Effect of salviae miltiorrhizae and ligustrazine hydrochloride injection on axonal regeneration and nerve growth factor expression in a rat model of sciatic nerve injury

BACKGROUND： Studies have shown that both salviae miltiorrhizae and ligustrazine can promote protein expression of nerve growth factor （NGF） and regeneration of peripheral nerve. OBJECTIVE： To verify the effect of salviae miltiorrhizae and ligustrazine hydrochloride injection on axonal regeneration and NGF protein expression in a rat model of sciatic nerve injury. DESIGN, TIME AND SETTING： A randomized, controlled, animal experiment was performed at the Laboratory of Traditional Chinese Medicine and the Institute of Bioengineering of Jinan University from July to December 2008. MATERIALS： Salviae miltiorrhizae and ligustrazine hydrochloride injection （containing 20 mg salviae miJtiorrhizae and 100 mg ligustrazine per 100 mL injection） was provided by Guizhou Baite Pharmaceutical, China; salviae miltiorrhizae and ligustrazine decoctions （containing 1 g raw drug per 1 mL decoction） were provided by Guangzhou Baiyunshan Factory for Traditional Chinese Medicine, China; rabbit-anti-rat NGF monoclonal antibody was provided by Beijing Biosynthesis Biotechnology, China. METHODS： A total of 80 healthy, male, Sprague Dawley rats were used to establish a sciatic nerve injury model via neurotomy, and were then randomly assigned to 4 groups： salviae miltiorrhizae and ligustrazine hydrochloride injection group （intraperitoneal injection of 35 mL/kg per day salviae miltiorrhizae and ligustrazine hydrochloride injection）, saIviae miltiorrhizae group （intragastric peffusion of 2 mL salviae miltiorrhizae）, ligustrazine group （intragastric peffusion of 2 mL ligustrazine）, and model group （intraperitoneal injection of 35 mL/kg per day saline）, with 20 rats in each group. Thereafter, rats in each group were then divided into 4 subgroups according to varying time points of 1, 2, 4, and 8 weeks post-surgery, with 5 rats in each subgroup. MAIN OUTCOME MEASURES： Axons were quantified using chromotrope 2R-brilliant green and silver staining combined with image analysis to calculate the axonal regeneration rate; NGF expression was detected using immunohistochemistry and Western blot analysis; toe interspace was measured by behavior at 4 and 8 weeks. RESULTS： With increasing time after sciatic nerve expression, and toe interspace gradually increased njury, the axonal regeneration rate, NGF protein At 4 and 8 weeks post-surgery, axonal regeneration rate and NGF protein expression were significantly increased in the injured tissue of the salviae miltiorrhizae and ligustrazine hydrochloride injection, salviae miltiorrhizae, and ligustrazine groups, compared with the model group （P 〈 0.05 or P 〈 0.01）, and toe interspace was remarkably enlarged （P 〈 0.05 or P 〈 0.01）, especially in the salviae miltiorrhizae and ligustrazine hydrochloride injection group. CONCLUSION： Salviae miltiorrhizae and ligustrazine hydrochloride injection promoted axonal regeneration and NGF protein expression in the injured sciatic nerve, and also enhanced neurofunctional recovery. Its effect was superior to salviae miltiorrhizae or ligustrazine alone.

CLINICAL ANALYSIS ON TREATMENT OF 40 CASES OF HYPERLIPEMIA WITH POINT-INJECTION OF RADIX SALVIAE MILTIORRZHIZAE INJECTION

In the present paper, the effect of point-injection of Radix Salviae Miltiorrhizae injectio on blood-lipid was observed in 65 cases of hyperlipemia. The 65 patients were divided into point-injection group (40 cases who were treated with point-injection of Radix Salviae Miltiorrhizae injectio and oral administration of Shujiangzhi) and control group (25 cases who were treated with oral administration of Shujiangzhi only). Results showed that the total effective rate of the point-injection group was significantly higher than that of the control group (P<0. 05); point-injection of Radix Salviae Miltiorrhizae injectio could effectively raise the level of HDL-C, decrease lower LDL-C and regulate estrogen level of women. The slow releasing action of red sage root solution in the topical acupoint region prolonged and enhanced its effect in lowering blood-lipid. There was a significant difference between the two groups in the effect of lowering blood-fat (P< 0. 01).

Microwave digestion polarography for determining seven trace elements in Salvia Miltiorrhiza Root and compound Salvia Miltiorrhiza Root injection simultaneously

The sensitive second derivative waves of Cu(Ⅱ),Pb(Ⅱ),Cd(Ⅱ),Ni(Ⅱ),Zn(Ⅱ),Fe(Ⅱ)and Mn(Ⅱ),forming in the substrate solution(pH=9.26)consisting of ammonia,ammonium chlorid,gelatin and ascorbic acid were researched.The peak potentials of the polarographic waves of the seven ions are at about 0.48,0.63,0.79,1.04,1.28,1.44 and 1.60 V respectively.Combining with microwave technique,a new method for the simultaneous determination of the seven trace elements in Chinese traditional medicine was developed.The method is easy to operate,rapid,simple and convenient.When the signal-to-noise rate equals 3,the detection limits of Cu,Pb,Cd,Ni,Zn,Fe and Mn are 4.2×10 3,5.3×10 3,2.1×10 3,5.8×10 4,3.0×10 3,7.7×10 4 and 1.1×10 3 μg/mL respectively.Well linear relationships exist between the concentrations and the peak currents when Cu,Pb,Cd,Ni,Zn,Fe and Mn concentrations are within 8.5×10 3 10,9.7×10 3 10,4.5×10 3 10,1.2×10 3 10,6.4×10 3 10,1.5×10 3 10 and 2.8×10 3 10 μg/mL,respectively.The method has been used to the simultaneous determination of the seven trace elements in Salvia Miltiorrhiza Root and compound Salvia Miltiorrhiza Root injection,the relative standard deviations(RSDs)of the Cu,Pb,Cd,Ni,Zn,Fe and Mn in the two medicines are 3.9% and 5.8%,4.0% and 4.1%,4.3% and 5.7%,4.9% and 5.3%,4.4% and 4.7%,3.5% and 4.0%,0.51% and 2.8%,respectively;the comparisons of the determination results with the values obtained by the standard method indicate that the presented method has very well veracity.

Effect of Salvia miltiorrhiza Injection Combined with Laparoscopic Reduction on Injury of Appendix in Patients with Intussusception

[Objectives] The aim was to analyze the effect of Salvia miltiorrhiza injection combined with laparoscopic reduction on the degree of appendix injury in intussusception.[Methods]Seventy-four children with intussusception who were treated in the Xuchang Municipal Hospital from August 2014 to August 2017 were randomly and evenly divided into two groups,control group and treatment group.The children in the control group were treated by laparoscopic reduction,and those in the treatment group were treated with S.miltiorrhiza injection combined with laparoscopic reduction.The clinical effect on intussusception in the children was compared between the two groups.[Results] Before treatment,no significant difference was founding serum NO level between the control and treatment groups(P > 0.05).On Day 1,3 and 5 of treatment,the serum NO levels of the treatment group[(74.16 ± 6.81),(61.98 ± 4.77) and(54.76 ± 4.36) μmol/L] were significantly lower than those of the control group[(89.67 ± 6.34),(84.75 ± 5.21) and(71.95 ± 4.58) μmol/L](P < 0.05).After treatment,the TNF-α and IL-6 levels of the treatment group[(184.32 ± 10.67) and(332.16 ± 34.17) pg/m L] were significantly lower than those of the control group[(268.26 ± 12.74) and(438.23 ± 35.26) pg/m L](P < 0.05);and the Chiu score of the treatment group(2.34 ± 1.12) was also significantly lower than that of the control group(4.85 ± 1.67)(P < 0.05).[Conclusions]For children with intussusception,S.miltiorrhiza injection combined with laparoscopic reduction is effective in reducing serum NO level and reducing the degree of appendix injury,which is worthy of clinical application.

Effect of salvia miltiorrhiza injection adjuvant therapy on systemic inflammatory stress state and nerve injury degree of children with bacterial Encephalitis

Objective:To discuss the effect of salvia miltiorrhiza injection adjuvant therapy on systemic inflammatory stress state and nerve injury degree of children with bacterial meningitis. Methods: 68 cases of children with bacterial meningitis who were treated in our hospital from Feb. 2014 to Jan. 2017 were selected and were divided into control group (34 cases) and observation group (34 cases) based on random number table, and patients in both groups were treated with continuous treatment for 10 d. Differences of inflammatory mediator, oxidative stress index, nerve injury markers content in cerebrospinal fluid in both groups were compared. Results: Before treatment, differences of inflammatory mediator, oxidative stress index, nerve injury markers content in cerebrospinal fluid in both groups had no statistical significance. 10 d after treatment, inflammatory mediator IL-6, PCT, sVCAM-1, CRP content in cerebrospinal fluid of children in observation group was lower than that in control group;oxidative stress index MDA content in cerebrospinal fluid was lower than that in control group, and SOD content was higher than that in control group;nerve injury markers MBP, NSE, GFAP content in cerebrospinal fluid was lower than that in control group.Conclusion: salvia miltiorrhiza injection adjuvant therapy could effectively relieve the systemic inflammatory stress state and reduce the nerve damages of children with bacterial meningitis.

丹参川芎嗪注射液联合依达拉奉治疗缺血性脑卒中的效果及对神经因子、miR-124、miR-182水平的影响

目的分析丹参川芎嗪注射液联合依达拉奉治疗缺血性脑卒中的效果及对神经因子、微小核糖核酸-124(miR-124)、微小核糖核酸-182(miR-182)水平的影响。方法选取2020年1月至2021年12月的80例缺血性脑卒中患者作为研究对象,根据不同用药方案将其分为对照组与观察组,各40例。对照组给予常规治疗+依达拉奉,观察组在对照组治疗基础上给予丹参川芎嗪注射液治疗。比较两组的治疗效果。结果观察组的治疗总有效率高于对照组(P<0.05)。治疗后,观察组的脑源性神经营养因子(BDNF)、神经生长因子(NGF)水平高于对照组,胶质纤维酸性蛋白(GFAP)水平低于对照组(P<0.05)。治疗后,观察组的miR-124表达水平高于对照组,miR-182表达水平低于对照组(P<0.05)。治疗后,观察组的美国国立卫生研究院卒中量表(NIHSS)评分低于对照组,简化Fugl-Meyer运动量表(FMA)、改良Barthel指数(MBI)评分高于对照组(P<0.05)。结论丹参川芎嗪注射液联合依达拉奉治疗缺血性脑卒中效果满意,不仅能够改善神经因子水平,还能有效调节miR-124、miR-182表达。

Anti-fibrotic Effects of Salvia miltiorrhiza and Ligustrazine Injection on LX-2 Cells Involved with Increased N-myc Downstream-Regulated Gene 2 Expression

Objective: To investigate the effects of Salvia miltiorrhiza and Ligustrazine Injection（SML） on proliferation and apoptosis of human hepatic stellate cell LX-2 and the expression of N-myc downstreamregulated gene 2（NDRG2, a tumor suppressor gene）. Methods: HSCs from the LX-2 cell line were cultured in vitro. The proliferative state of different initial LX-2 cell numbers was measured using a 3-（4,5-dimethylthiazol-2-yl）-2,5-diphenyltetrazolium bromide（MTT） colorimetric assay. LX-2 cells were plated in 96-well plates at an approximate density of 2.50×10;cells/mL and cultured for 24 h followed by the application of different concentrations of SML（1, 2, 4 and 8 μL/mL）. Cell proliferation was measured using the MTT assay at 24 and 48 h. Apoptosis was detected by flow cytometry at 24 h. LX-2 cells were treated with different concentrations of SML and extracted with protein lysis buffer. The levels of NDRG2 and β-catenin were measured by Western blot. Results: With the exception of the 1 and 2 μL/mL concentrations, 4 and 8 μL/mL SML inhibited cell proliferation in a concentration-dependent manner at 24 and 48 h（P<0.05）. With the exception of the 1 and 2 μL/mL concentrations, the NDRG2 expression level was greatly increased in a concentration-dependent manner. However, the level of β-catenin was unaffected. Conclusion: SML inhibit LX-2 cell proliferation in a concentration-dependent manner, and the mechanism may be associated with NDRG2 over-expression.

丹参及丹参注射液指纹图谱的HPLC-MS研究

目的 采用 HPL C- U V- MS法对丹参药材、丹参注射液中间体及丹参注射液进行指纹图谱的研究。方法 采用 Alltim a C1 8分析柱 ,甲醇 -水 -冰醋酸梯度洗脱系统 ,流速 :1m L / m in,检测波长 :2 81nm ,MS同时记录总离子流(TIC)色谱图。结果 得到分离度较好的丹参药材、中间体及注射液的 HPL C- UV及 HPL C- MS指纹图谱。结论 为丹参药材、中间体及注射液的质量控制提供全面、可靠的依据。

丹参注射液协同地塞米松抑制支气管哮喘大鼠肺内IL-13和嗜酸性粒细胞趋化因子的表达

目的探讨丹参注射液协同地塞米松抑制支气管哮喘气道变应性炎症作用的分子机制。方法40只SD大鼠随机分成正常组、模型组、地塞米松组、丹参组和联合组,每组8只。除正常组不造模外,其余4组均造成哮喘模型,且各组给予相应的药物。HE染色行肺组织病理学检查;收集支气管肺泡灌洗液(BALF),行白细胞(WBC)及嗜酸性粒细胞(Eos)计数;应用免疫组织化学SP法和逆转录-聚合酶链反应(RT-PCR)测定肺组织白细胞介素-13(IL-13)和嗜酸性粒细胞趋化因子(Eotaxin)表达。结果病理组织学显示:丹参组大鼠呈中度炎症变化,地塞米松组、联合组呈轻度炎症变化。BALF中WBC及Eos计数:3个用药组较模型组明显减少(P<0·05),联合组减少的程度大于地塞米松组、丹参组(P<0·05或P<0·01)。肺组织IL-13和Eotaxin表达:3个用药组较模型组明显减少(P<0·05),且联合组减少程度大于地塞米松组、丹参组(P<0·05或P<0·01);IL-13和Eotaxin表达呈正相关(r=0·92,P<0·01)。结论丹参注射液可降低哮喘模型鼠肺内IL-13和Eotaxin的表达,与地塞米松有协同发挥抗气道炎症作用。

丹参注射液抑制大鼠心肌缺血-再灌注损伤诱导的细胞凋亡

目的:观察丹参注射液(SMI)对大鼠心肌缺血-再灌注损伤诱导的细胞凋亡的影响并探讨其机制。方法:采用Langendorff离体灌流装置复制大鼠心肌缺血-再灌注损伤模型。实验随机分为正常对照组(Control),缺血-再灌注损伤组(I/R),丹参注射液保护组(SMI)。生化法检测冠脉流出液乳酸脱氢酶(LDH)的活性和组织匀浆超氧化物歧化酶(SOD)的活性及丙二醛(MDA)的含量;免疫组化法检测Bcl-2、Bax和caspase-3的表达变化;采用缺口末端标记法(TUNEL)检测心肌细胞凋亡情况;电镜观察心肌组织超微结构。结果:与正常对照组比较,缺血-再灌注损伤组冠脉流出液中LDH漏出增加;组织匀浆中SOD的活性降低、MDA的含量增加;Bcl-2表达减少,Bax和caspase-3表达均增加;细胞凋亡加重;心肌超微结构损伤加重。丹参注射液可以减轻心肌缺血-再灌注损伤,表现为冠脉流出液中LDH漏出减少;组织匀浆中SOD的活性升高、MDA的含量降低;Bcl-2表达增加;Bax和caspase-3表达均减少;细胞凋亡减轻;心肌超微结构损伤减轻。结论:丹参注射液通过下调Bax和caspase-3基因表达,上调Bcl-2基因表达抑制心肌缺血-再灌注损伤诱导的细胞凋亡。

3.0T BOLD-fMRI评价丹参注射液对大鼠对比剂肾病的保护作用:与病理对照研究

目的采用血氧水平依赖功能MRI(BOLD-fMRI)技术评估丹参注射液对大鼠对比剂肾病(CIN)的保护作用。方法将60只SD大鼠随机均分为丹参组和对照组进行BOLD-fMRI,分别于注射对比剂前、后连续注射丹参注射液及生理盐水7天(每天1次);于注射对比剂前、注射后20min、24h、48h、72h和7天点每组各取5只大鼠行BOLD-fMRI扫描,测量大鼠肾脏外髓部R*2值,后取大鼠肾脏行病理检查,评价外髓部肾小管损伤情况,分析和比较两组R*2值及病理损伤变化过程和差异,评价R*2值与病理损伤相关性。结果两组大鼠外髓部R*2值于注射对比剂后20min均增高,随后对照组先回落后复升高,丹参组持续回落;注射对比剂前及注射后20min和48h丹参组R*2值高于对照组(P均<0.05),注射后72h和7天丹参组R*2值低于对照组(P均<0.05)。病理结果表明两组大鼠注射对比剂后20min外髓部肾小管均出现损伤,注射后7天对照组病理损伤评分达最高,丹参组恢复至注射前水平;注射对比剂后20min丹参组病理损伤评分明显高于对照组(P<0.01),24h^7天丹参组病理损伤评分均低于对照组,除24h外,余时间点两组间差异均有统计学意义(P均<0.05)。肾脏外髓部R*2值与肾小管损伤病理损伤评分呈正相关(右肾:r=0.58,左肾:r=0.52,左右肾合计:r=0.56;P均<0.001)。结论丹参注射液对CIN具有预防和治疗作用,其效果可通过3.0TBOLD-fMRI进行检测。

丹参注射液对Ⅱ型糖尿病肾病患者血液IL-6 IL-8和TNF-α水平的影响

目的:观察丹参注射液对Ⅱ型糖尿病肾病患者血液IL-6、IL-8和TNF-α的影响,探讨丹参注射液治疗Ⅱ型糖尿病肾病的机制。方法:采用丹参注射液治疗32例II型糖尿病肾病患者,取常规西药组32例作为对比观察,于治疗前后检测患者血液中细胞因子IL-6、IL-8和TNF-α水平。结果:丹参注射液治疗II型糖尿病肾病总有效率71.8%,而对照组总有效率为43.8%,两组比较差异有显著性;治疗前丹参注射液治疗组IL-8、IL-6和TNF-α水平与西医治疗对照组比较差异无显著性;治疗后两组IL-8、IL-6和TNF-α均显著降低,但丹参注射液治疗组下降更为明显,与西医治疗组比较差异有显著性;治疗后丹参注射液治疗组24h尿蛋白量显著低于对照组;且丹参注射液治疗组治疗前和治疗后24h尿蛋白量与IL-8、IL-6和TNF-α水平呈正相关。结论:丹参注射液结合西医治疗对II型糖尿病肾病有显著疗效,可能与丹参注射液能调节炎性细胞因子的产生,抑制炎症反应有关。

丹参注射液对溃疡性结肠炎患者D-二聚体含量的影响及意义

目的探讨丹参注射液对活动性溃疡性结肠炎(UC)患者血清中D-二聚体含量的影响及临床意义。方法将54例活动性UC患者随机分为柳氮磺胺吡啶(SASP)组和SASP+丹参组,分别测定治疗前后D-二聚体含量变化并观察其临床疗效。结果2组均可使血清中D-二聚体含量下降,但SASP+丹参组较SASP组下降明显,有非常显著性差异(P<0.01),且总有效率达93%,而SASP组仅为74%。结论丹参注射液可明显降低血清中D-二聚体含量,对UC患者具有较好的治疗作用。

丹参注射液及其活性成分与低强度He-Ne激光联用对牛中性粒细胞呼吸暴发的抑制效应

目的 :丹参注射液与低强度He Ne激光联用在临床上治疗缺血、缺氧性心、脑血管疾病取得良好疗效 ,但其机制尚未完全阐明。观察丹参注射液及其活性成分与低强度He Ne激光联合作用在细胞水平的效应 ,以进一步探讨其抗缺血、缺氧性损伤的机制。方法 :应用化学发光法检测了丹参注射液及其主要活性成分丹参素和丹参酮分别与低强度He Ne激光联用对牛中性粒细胞(PMN)呼吸暴发的影响。结果 :低强度He Ne激光、丹参注射液、丹参素、丹参酮都能对PMN的呼吸暴发产生抑制效应 ,丹参注射液或其活性成分与低强度He Ne激光联用抑制效果更明显。结论 :丹参注射液或其活性成分与低强度He Ne激光联用能够协同抑制PMN的呼吸暴发。

前列地尔注射液、倍他司汀联合丹参川芎嗪注射液治疗椎-基底动脉供血不足的疗效

目的探讨前列地尔注射液、倍他司汀联合丹参川芎嗪注射液治疗椎-基底动脉供血不足的临床疗效。方法将86例椎-基底动脉供血不足患者按随机数字表法分为2组:联合治疗组46例和丹参川芎嗪组40例。2组患者均采用倍他司汀联合丹参川芎嗪注射液治疗。在此基础上,联合治疗组加用前列地尔注射液治疗。观察2组患者治疗前、治疗14 d后脑血流动力学指标[左侧椎动脉(LVA)和右侧椎动脉(RVA)的收缩峰流速和舒张末期流速]、纤维蛋白原水平的变化及治疗14 d后临床疗效、不良反应等情况。结果联合治疗组总有效率明显高于丹参川芎嗪组(P<0.05),联合治疗组治疗14 d后纤维蛋白原水平明显低于丹参川芎嗪组(P<0.05),联合治疗组治疗14 d后收缩峰流速LVA、收缩峰流速RVA、舒张末期流速LVA、舒张末期流速RVA血流速度均较丹参川芎嗪组增快(均P<0.05)。联合治疗组有1例出现胃肠不适,有2例出现注射部位发红、搔痒,均可忍受,不影响治疗。丹参川芎嗪组无不良反应发生。结论前列地尔注射液、倍他司汀联合丹参川芎嗪注射液治疗椎-基底动脉供血不足,能显著的扩张脑血管,改善椎动脉的血流量,增加脑血流速度;有效的降低纤维蛋白原水平,且不良反应少。

丹参注射液对重症急性胰腺炎大鼠胰腺NF-κB活化的影响

目的观察重症急性胰腺炎(SAP)大鼠胰腺核因子-κB(NF-κB)活性的变化及丹参注射液对其的影响,从而探讨丹参注射液治疗急性胰腺炎的机理。方法将大鼠随机分为正常对照组、SAP组和丹参治疗组3组,采用腹腔和皮下同时注射L-精氨酸的方法制成大鼠急性胰腺炎模型,分别测量血浆、腹水淀粉酶,并采用免疫组化方法测定胰腺组织中NF-κB的表达。结果与正常对照组比较,SAP组血浆、腹水淀粉酶水平明显增高,胰腺组织NF-κB表达强度升高(P<0.05);丹参治疗组上述指标与SAP组相比均有明显下降(P<0.05),且胰腺的病理损伤减轻,存活时间更长。结论丹参注射液可能通过降低胰腺组织中NF-κB的表达而对急性胰腺炎的治疗发挥作用。

丹参川芎嗪注射液对急性肺栓塞大鼠血清生长分化因子-15及NT-proBNP的影响

目的探讨丹参川芎嗪注射液对急性肺栓塞(APE)大鼠血清生长分化因子-15(GDF-15)及氨基末端脑钠肽前体(NT-proBNP)的影响及意义。方法健康雄性Wistar大鼠64只,随机分为7天组(n=32)和7小时组(n=32),每组大鼠又随机分为栓塞组(n=8)、肝素组(n=8)、丹参川芎嗪组(n=8)和联合用药组(n=8)。通过异体血栓输入复制APE模型。分别于注栓后7天、7小时取血,离心后通过酶联免疫吸附试验检测血清GDF-15及NT-proBNP的浓度并进行分析。结果肝素组、丹参川芎嗪组、联合用药组于各时间段血清GDF-15、NT-proBNP浓度较栓塞组均有降低,但程度不同,其中联合用药组于7小时血清GDF-15、NT-proBNP浓度较栓塞组改变有显著意义(P<0.05)。结论应用丹参川芎嗪注射液后急性肺栓塞大鼠相较于未应用的大鼠血清生长分化因子-15及NT-proBNP均有不同程度的降低,尤其联合低分子肝素进行治疗,两项生物标记物降低更为显著。

丹参川芎嗪对野百合碱诱导的肺动脉高压大鼠ET-1、NO和RVHI的影响

目的 观察丹参川芎嗪对野百合碱（MCT）诱导的肺动脉高压大鼠血浆中内皮素-1（ET-1）、一氧化氮（NO）含量、大鼠的平均肺动脉压（mPAP）、右心室肥厚指数（RVHI）的影响.方法 SD大鼠90只,随机分为对照组、模型组、丹参川芎嗪组.采用MCT进行一次性皮下注射（60 mg/kg）造模,28天后测定血浆中ET-1、NO的含量及mPAP、RVHI.结果 模型组及丹参川芎嗪组mPAP、ET-1、RVHI高于对照组（P＜0.05）,模型组及丹参川芎嗪组NO含量低于对照组（P＜0.05）.结论 丹参川芎嗪可能通过抑制血管壁的炎症、调节血管扩张和收缩失衡、减轻右心室肥厚,从而降低mPAP.